ANI Pharmaceuticals
ANIP
#4819
Rank
NZ$3.17 B
Marketcap
NZ$141.54
Share price
-1.17%
Change (1 day)
48.70%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.07 Billion

According to ANI Pharmaceuticals's latest financial reports the company's total debt is NZ$1.07 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ANI Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.10 B144.97%
2023-12-31NZ$0.45 B0.1%
2022-12-31NZ$0.45 B7.26%
2021-12-31NZ$0.42 B63.48%
2020-12-31NZ$0.25 B-6.69%
2019-12-31NZ$0.27 B1.09%
2018-12-31NZ$0.27 B-3.84%
2017-12-31NZ$0.28 B62.91%
2016-12-31NZ$0.17 B5.09%
2015-12-31NZ$0.16 B21.88%
2014-12-31NZ$0.13 B
2013-12-31N/A-100%
2012-12-31NZ$9.58 M-56.86%
2011-12-31NZ$22.21 M-7.6%
2010-12-31NZ$24.04 M4.71%
2009-12-31NZ$22.96 M
2000-12-31NZ$1.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Jazz Pharmaceuticals
JAZZ
NZ$9.39 B 775.13%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ$8.87 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 2,652.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
NZ$105.32 B 9,709.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
NZ$1.10 B 3.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$4.53 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$15.63 B 1,356.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.43 B 5,062.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
NZ$15.48 B 1,342.14%๐Ÿ‡ฌ๐Ÿ‡ง UK